In a recent presentation delivered at MIT, Professor Edward Roberts and Charles Eesley discussed the findings of a report that they co-authored on the role
The period of data protection allocated to research-based, innovative drug companies is a hotly debated topic in the pharmaceutical industry and beyond. This period of protection
Open core licensing, also known as commercial extensions, is a licensing regime that offers core components for free, but charges licensees for additional premium products.
Despite the ominous verdict from the Swedish court which sentenced The Pirate Bay (TPB) operators to a year in prison and a penalty of US
A recent article written by Colin Campbell from Maclean’s discussed the unfortunate fact that Canada is usually far behind other nations when it comes to
James Gannon is an Osgoode Hall alumnus and is currently an articling student at McCarthy Tétrault. Jonathan Frydman recently completed his second year of the
